image credit- shutterstock
Algorithm, a pioneering regional pharmaceutical manufacturer has announced the signing of a strategic partnership agreement with Batterjee Pharma, a leading Saudi pharmaceutical company, becoming the first Lebanese company to localise its portfolio in the Kingdom.
The agreement covers the manufacturing and supply of several EU & Japanese licensed Algorithm products.
The collaboration will kick off with products targeting the treatment of critical therapeutic areas as hyperlipidemia, dyslipidemia & hypertension with full technology transfer by mid-2026.
Aligned with Kingdom of Saudi Arabia's (KSA) Health Sector Transformation Programme under Vision 2030, this partnership will strengthen the Kingdom’s healthcare infrastructure, reduce reliance on imports, and enhance treatment standards.
